The Executional Excellence issue of Perspective magazine is live
|23rd May 2017
Blue Latitude Health has spent 14 years building a truly world-class creative marketing consultancy. Combining the best of consultancy and agency to solve the most complex of healthcare challenges at a brand, portfolio and organisational level.
What drives us at BLH is the opportunity to make a real difference – and for our clients, that difference is measured both in customer outcomes and commercial outcomes. Creating work that stands out is important, but creating work that delivers results is imperative. In this edition, we explore topics around the ‘executional excellence’ theme – creating work that works.
Read more about:
- How to plan and execute the perfect congress experience
- How to find that global sweet spot - international creative work that works
- What an EMEA Marketing Lead at Janssen looks for in an exceptional creative campaign
- How global organisations can improve the localisation of digital services in pharma
- How we created a properly integrated full-service global team by baking in creative services to our consultancy approach.
Click the button below to enter your details and receive your free digital copy.
Empowered patients: shaking the foundations of healthcare
|16th August 2019
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
A uniquely English genomic medicine service
|26th July 2019
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
Diagnosing the lag in neuropsychiatric treatments
|16th July 2019
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.